Certain polyunsaturated fatty acids (PUFAs) may have a favorable effect on disease progression and survival for patients with amyotrophic lateral sclerosis.
The incidence and prevalence of myasthenia gravis have increased in the United States, likely due to increased diagnosis and more awareness of the disease over time.